Amble Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This research compound demonstrates potential for improving glycemic control through its unique mechanism of action.
The white to off-white powder formulation of Amble Tirzepatide offers researchers a stable and pure material for investigative purposes. With molecular formula C225H348N48O68 and molecular weight of 4813, this compound represents an important area of metabolic research.
Our Amble Tirzepatide is synthesized under strict quality control measures to ensure consistent purity exceeding 99%. The product is available in various packaging configurations to meet different research requirements.
Important Note: This Amble Tirzepatide product is prepared by chemical synthesis and is intended for research use only. It is not for human consumption or clinical application.
Researchers studying metabolic disorders may find Amble Tirzepatide particularly valuable for investigating dual receptor agonist mechanisms. The compound's ability to simultaneously target both GIP and GLP-1 pathways makes it a unique research tool.